Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma by Lin, Yuan et al.
Association study of genetic variation in DNA repair pathway 
genes and risk of basal cell carcinoma
Yuan Lin1, Harvind S. Chahal2, Wenting Wu1, Hyunje G. Cho2, Katherine J. Ransohoff2, 
Fengju Song3, Jean Y. Tang2, Kavita Y. Sarin2,*, and Jiali Han1,*
1Department of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin & Bren 
Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA
2Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Epidemiology and Biostatistics, Tianjin, National Clinical Research Center of 
Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer 
Institute and Hospital, Tianjin 300060, China
Abstract
DNA repair plays a critical role in protecting the genome from ultraviolet radiation and 
maintaining the genomic integrity of cells. Genetic variants in DNA repair-related genes can 
influence an individual’s DNA repair capacity, which may be related to the risk of developing 
basal cell carcinoma (BCC). We comprehensively assessed the associations of 2,965 independent 
single-nucleotide polymorphisms (SNPs) across 165 DNA repair pathway genes with BCC risk in 
a genome-wide association meta-analysis totaling 17,187 BCC cases and 287,054 controls from 
two data sets. After multiple testing corrections, we identified three SNPs (rs2805831 upstream of 
XPA: OR = 0.93, P = 1.35 × 10−6; rs659857 in exon of MUS81: OR = 1.06, P = 3.09 × 10−6; and 
rs57343616 in 3′ UTR of NABP2: OR = 1.11, P = 6.47 × 10−6) as significantly associated with 
BCC risk in meta-analysis, and all of them were nominally significant in both data sets. 
Furthermore, rs659857 [T] was significantly associated with decreased expression of MUS81 
mRNA in the expression quantitative trait locus (eQTL) analysis. Our findings suggest that the 
inherited common variation in three DNA repair genes-XPA, MUS81 and NABP2-may be 
involved in the development of BCC. To our knowledge, our study is the first report thoroughly 
examining the effects of SNPs across DNA repair pathway genes on BCC risk based on a genome-
wide association meta-analysis.
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Introduction
Skin cancer is the most frequent malignancy among Caucasians in the United States1 as well 
as other countries.2 Current estimates are that one in five Americans will develop skin 
cancer during his or her lifetime.3 Basal cell carcinoma (BCC), a basal keratinocyte tumor in 
the epidermis, accounts for 80–90% of all primary skin cancers.4 In the USA, more than one 
million BCC cases are diagnosed each year.5 Although BCCs are slow-growing, locally 
invasive tumors, they can lead to extensive morbidity through recurrence and tissue 
destruction, imposing a growing burden on healthcare services.
Ultraviolet (UV) radiation is generally accepted as the most important environmental risk 
factor for BCC, causing cellular DNA damage by inducing the formation of DNA 
photoproducts, bulky monoadducts, crosslinks, and oxidative damage.6–7 One essential 
defense mechanism against skin cancer is the ability to repair DNA damage induced by UV 
light. DNA repair pathway genes form a complex network that continuously monitors 
chromosomes to correct damaged nucleotide residues generated by exposure to carcinogens 
and cytotoxic compounds.8 Toxic and mutagenic consequences are minimized by discrete 
DNA repair pathways such as base excision repair (BER), nucleotide excision repair (NER), 
mismatch repair (MMR), homologous recombination (HR), and non-homologous end-
joining (NHEJ).8 Reduced capacity for DNA repair after UV light-induced DNA damage 
has been established as an independent risk factor for BCC development.9 The importance 
of NER in the etiology of skin cancer has been clearly illustrated. It is the main process 
responsible for repairing DNA photoproducts, which is generated upon the direct absorption 
of UVB (280–320 nm).10 However, studies have shown that UVA (320–400 nm) 
predominantly present in sunlight, induces oxidative DNA damage, which further lead to 
double-strand breaks (DSBs).11, 12 This process may also contribute to the development of 
non-melanoma skin cancer.13 Homologous recombination (HR) and non-homologous end-
joining (NHEJ) are two distinct mechanisms in the repair of DSBs in mammalian cells. 
Therefore, their repair capacity may influence individual’s risk of UV induced skin cancer.13
Genetic variation in DNA repair-related genes can modulate DNA repair capacity 14,15 and 
may further affect BCC susceptibility. A number of studies have examined the associations 
between polymorphisms in DNA repair genes and BCC risk, with inconsistent findings.
13, 16–20
 However, many of these studies focused on only a few genes and only functional 
single nucleotide polymorphisms (SNPs), that is, instances in which variation in a single 
base pair in the DNA results in a different amino acid upon translation. As the number of 
human DNA repair pathway genes identified has risen to as many as 165,8 a more complete 
and systematic evaluation of DNA repair gene variation in relation to BCC is now called for. 
In addition, the function of ‘silent’ polymorphisms under different mechanisms has been 
shown, such as epigenetic regulation of promoters,21 pre-transcriptional regulation via 
miRNA targeting of 3′ untranslated regions,22 and post-translational modification via 
synonymous polymorphisms in exons.23 Including markers from each of these regions is 
advantageous for identifying new BCC susceptibility-related variants. Therefore, in the 
present study, we thoroughly examine the effects of common genetic variation across DNA 
repair-related pathway genes on BCC risk by extracting genotyping data on 165 related 
genes from a genome-wide association meta-analysis.
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Materials and methods
Study population
This study was based on a genome-wide association meta-analysis of BCC consisting of two 
GWAS datasets - the BCC case-control study within 23andMe research and the BCC case-
control study within the Nurses’ Health Study (NHS) and Health Professionals Follow-Up 
Study (HPFS). A total of 17,187 cases and 287,054 controls of European ancestry were 
included. This study was performed in accordance with the ethical standards laid down in 
the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
The first GWAS set comprised 12,945 self-reported BCC cases and 274,252 controls among 
23andMe research participants, who were described in a previous study.24 Briefly, 23andMe 
gathers genetic information by genotyping sample material provided by its customers; 
phenotypic information is collected via customer responses to online surveys. All 
information came from 23andMe research participants who provided informed consent to 
take part in this research, in accord with 23andMe’s human subjects protocol (reviewed and 
approved by Ethical and Independent Review Services, a AAHRPP-accredited IRB). 
Validation assessment with adjudicated medical records demonstrated a high validity of self-
reported diagnosis with sensitivity and specificity of 93% and 99%, respectively. The second 
GWAS consisted of 4,242 self-reported BCC cases and 12,802 controls from the NHS and 
the HPFS, whose participants were described in a previous study.24 The NHS consists of 
121,700 female registered nurses between the ages of 30 and 55 years at enrollment. They 
returned the initial self-administered questionnaire in 1976 and then completed 
questionnaires biennially. Blood samples were collected from 32,826 participants. 
Information on BCC development was first collected in the 1984 questionnaire. For the 
HPFS, in 1986, 51,529 men in health professions aged 40–75 years answered a detailed 
mailed questionnaire, and 18,159 participants provided blood samples. Updated information 
was obtained by questionnaire every two years. Information on BCC development was first 
collected in the 1986 questionnaire. The protocol was approved by the Institutional Review 
Board at Brigham and Women’s Hospital and the Harvard School of Public Health. All of 
the participants provided informed consent.
Two genome-wide association analyses and meta-analyses
Association analysis for 23andMe research was performed using unconditional logistic 
regression, assuming an additive model with adjustment for age, sex, and population 
stratification, generating the following model: BCC diagnosis ~ age + sex + pc.0 + pc.1 + 
pc.2 +pc.3 + pc.4 + genotype. Further information on the analysis was provided previously.
24
 The association analysis for Harvard GWAS was also described in a previous study.24 In 
brief, association analysis was performed using unconditional logistic regression under an 
additive model with adjustment for age, sex, and the first five principal components, 
generating the following model: BCC diagnosis ~ age + sex + pc.1+ pc.2 +pc.3 + pc.4 + pc.
5 + genotype. After the imputation process was conducted in two datasets separately, we had 
12,725,604 SNPs in the 23andMe dataset and 8,557,099 SNPs in the Harvard dataset. A 
total of 8,262,448 SNPs available in both datasets were included in further meta-analysis. 
Betas from the two GWAS studies were combined by a meta-analysis, with weights 
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proportional to the inverse variance of the beta in each study. Heterogeneity of per-SNP 
effect sizes in studies contributing to each GWAS and the overall meta-analyses was 
assessed by the Q test and the I2 index, and fixed effects meta-analysis was conducted. A 
total of 8,262,448 SNPs in both datasets were included in further analysis.
DNA repair genes and SNPs selection
We selected human DNA repair pathway genes according to a review article.8 A complete 
list of these genes can be found on http://sciencepark.mdanderson.org/labs/wood/
DNA_Repair_Genes.html. These pathways/genes are provided in Supplementary Table S1. 
SNPs within the 165 DNA repair-related genes and their ±50 kb flanking regions were 
extracted for further analysis.
Exposure data collection
In the Harvard cohort, information regarding skin cancer risk factors was obtained from the 
retrospective supplementary questionnaire. Information on history of residence (states and 
towns) was collected, and 11 states of residence of cohort members at baseline were grouped 
into three regions: Northeast (Connecticut, Massachusetts, Maryland, New Jersey, New 
York, and Pennsylvania), North Central (Michigan and Ohio), and West and South 
(California, Texas, and Florida). To estimate sunlight exposure for each subject, a UV 
database for all 50 U.S. states was developed using reports from the Climatic Atlas of the 
United States, which reports mean daily solar radiation (in Langleys) at the earth’s surface 
for weather stations around the country (National Oceanic and Atmospheric Administration; 
1983). Records of average annual solar radiation for January and July were extracted to 
represent winter and summer radiation, respectively. The mean solar radiation for each 
individual’s past (at different age categories) and current residence was derived from the UV 
values measured at the nearest weather station, and both summer and winter radiation 
indices were developed for each residence. We also developed a cumulative lifetime sun 
exposure by combining the UV database and the information obtained from the 
supplementary questionnaires.
Statistical analysis
We used an online analysis tool - SNP Effect Concordance Analysis (SECA; http://
neurogenetics.qimrberghofer.edu.au/SECA/) - to remove SNPs in linkage disequilibrium 
(LD) (r2 > 0.1) within 10 Mb and kept a set of independent SNPs with the lowest P values in 
overall meta-analysis. Among these independent SNPs, we further selected those that 
reached nominal significance level of P < 0.05 in both GWAS datasets with consistent 
direction of association as index SNPs. We performed eQTL analysis using the Genotype-
Tissue Expression (GTEx) Portal (http://www.gtexportal.org/home/). Genotype data from 
1000G Phasel v3 CEU (b37 rsIDs) was used for LD estimation. To evaluate interactions 
between sun exposure and genotypes, we modeled sun exposure level as a continuous 
variable using the median value among controls for each tertile in the Harvard cohort, which 
allowed us to assess the statistical significance of interaction by likelihood ratio tests. We 
also constructed a multivariable confounder score to summarize pigment traits in the 
Harvard cohort.25 Briefly, we applied the logistic regression coefficients from a 
multivariable model for skin cancer risk, including age, gender, natural hair color, times of 
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blistered sunburn and tendency to sunburn during adolescence, to each individual’s values 
for the latter three of these variables and summed the values to compute a pigment score in 
the logit scale. We used the median value for this score among controls to identify 
participants with low, intermediate, and high pigmentation. All statistical tests were two-
sided.
Results
The distribution of cases and controls according to gender and age is provided in Table 1. In 
the overall meta-analysis of two GWAS datasets totaling 17,187 cases and 287,054 controls, 
we extracted 59,559 SNPs across the 165 DNA repair-related genes and within their ± 50kb 
flanking regions. After removing SNPs in LD (r2 > 0.1), 2,965 independent SNPs remained 
(Materials and methods). We found 14 SNPs significantly associated with BCC risk after 
performing multiple testing corrections with the Bonferroni single-step method (corrected α: 
0.05/2,965 = 1.69 × 10−5). Among them, eight SNPs reached a nominal significance level of 
P < 0.05 in both GWAS datasets with a consistent direction of association. These eight SNPs 
are across or within ± 50-kb flanking regions of five different DNA repair genes - XPA 
rs2805831, MUS81 rs659857, NABP2 (also known as SSB1) rs57343616, FANCA 
rs149705807 rs9933498 rs12931267 rs17232309, and TP53 rs35850753.
Among the five DNA repair pathway genes, three - XPA rs2805831 (NER), MUS81 
rs659857 (HR), and NABP2 rs57343616 (with known DNA repair function) - were 
identified for the first time as related to BCC susceptibility (Table 2). Their minor allele 
frequency (MAF), imputation quality, and effect heterogeneity statistics are provided in 
Supplementary Table S2. FANCA is located 180 kb from the MC1R gene, a well-known 
critical pigmentation gene consistently associated with BCC risk.5 We evaluated the effect of 
one BCC-susceptibility SNP (rs1805007) in the MC1R gene on the association between 
FANCA and BCC risk. After adjusting for this SNP, the FANCA variants were no longer 
associated with BCC risk. This suggested that the FANCA signals we detected in the present 
study are explained by the MC1R variants nearby. TP53 rs35850753 is in strong LD with 
rs78378222 (r2 = 0.82), which was demonstrated to be significantly associated with BCC 
risk in a previous GWAS.25 The data of the other five BCC susceptibility SNPs located in 
previously reported loci were shown in Supplementary Table S3.
Furthermore, we performed expression quantitative trait locus (eQTL) analysis using GTEx 
Portal, and found that the risk allele (T) of rs659857 was significantly associated with 
decreased expression of MUS81 mRNA in 338 whole blood samples (P = 0.018), while no 
eQTL effects were identified for the other two index SNPs.
We evaluated potential gene-environment interactions between our index polymorphisms 
and cumulative sun exposure among the pooled population in the Harvard dataset. No 
statistically significant interactions were identified (P values for interaction tests > 0.05). We 
further conducted interaction analyses between polymorphisms and pigment score created in 
the Harvard dataset, and again no significant interactions were identified (P values for 
interaction tests > 0.05). When stratified by sun exposure level (low, intermediate, or high) 
and pigment score (low, intermediate, or high) among the pooled population in the Harvard 
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dataset, we did not find any significant difference of effect sizes in subgroups (all P values 
for heterogeneity > 0.05).
Because the association of the three SNPs with BCC risk may also be mediated by LD with 
other potential causal loci, we conducted pair-wise LD analysis in distinct gene regions. 
Some polymorphisms in LD (r2 > 0.1) with the three index SNPs also exhibited significant 
associations with BCC risk (P < 1.69 × 10−5), but none showed stronger effect than the 
index SNPs (Supplementary Table S4).
Discussion
In view of the plethora of types of lesions, no single repair process can cope with all 
varieties of damage. Instead, numerous DNA repair pathways form a complex network that 
protects the genome’s integrity from exogenous (radiation, chemicals, drugs) and 
endogenous (free radicals) damage.8 Their biological importance is demonstrated by the 
existence of dramatic diseases caused by a deficiency in one of these pathways.10 Because 
of the importance of maintaining genomic integrity in the general and specialized functions 
of cells, genes coding for DNA repair molecules have been proposed as candidate genes for 
skin cancer susceptibility. There are some published data on select genetic polymorphisms in 
DNA repair genes and BCC risk, but the findings are not consistent. In our present candidate 
gene analysis based on a large GWAS meta-analysis, we found evidence that common 
variants in XPA, MUS81, and NABP2 genes are significantly associated with BCC risk.
rs2805831 at 9q22.33 resides 7 kb upstream of the XPA gene, which is a necessary 
component of the NER pathway. NER is a versatile repair system responsible for removing a 
wide variety of bulky, helix-distorting lesions that interfere with base pairing and generally 
obstruct transcription and normal replication.10 NER’s importance in the etiology of skin 
cancer is clearly illustrated by classical xeroderma pigmentosum (XP), a heterogeneous 
genetic disorder in which rare, highly penetrant mutations disrupt NER’s ability to remove 
DNA photoproducts. XP is caused by mutations in one of eight genes (XP complementation 
groups A-G), and patients exhibit extremely high sensitivity to UV radiation and have a 
more than 1,000-fold increased risk of skin cancers.27,28 It thus stands to reason that more 
common but less penetrant NER gene variants may be associated with BCC risk in the 
general population. It has been demonstrated that null mutations in the XPA gene lead to the 
most severe form of XP.29 The index SNP XPA rs2805831 is in LD with rs1800975 (r2 = 
0.106, D′= 1.000), which have been associated with various cancers. We observed that in 
our study, the association of rs1800975 with BCC in the two GWAS data sets was 
inconsistent and it was not statistically significant after multiple testing corrections in the 
meta-analysis. Miller et al. have associated rs1800975 [T] allele with decreased risk of BCC 
and SCC in a previous study with small sample size (886 BCC cases, 682 SCC cases vs. 796 
controls), and the association was marginally significant (P = 0.03 for BCC and P = 0.05 for 
SCC).19 However, it was reported that [T] allele was significantly associated with increased 
risk of some other cancers like lung cancer, breast cancer, gastric cardiac adenocarcinoma 
and oral premalignant lesions.30–33 In our data, [T] allele was associated with elevated BCC 
risk, but the association was not significant. The association of XPA with skin cancer may be 
driven by other markers, including rs2805831that we reported in the present study.
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Another index SNP rs659857 is a synonymous variant and also an eQTL of MUS81 in 
whole blood. We found that the rs659857 risk allele (T) was associated with decreased 
expression of MUS81 mRNA. MUS81 is an important gene involved in the HR, which is 
responsible for repairing DSBs in mammalian cells. According to previous studies, UVA-
induced oxidative DNA damage and DNA replication blockage by UVB-induced 
photoproducts can lead to DSBs.13 To our knowledge, biological evidence on the 
involvement of DSBs in non-melanoma skin cancer is weak. Recent work has connected β-
human papillomavirus genus (β-HPVs) to non-melanoma skin cancers.34 Wallace et al. 
further explored the underlying mechanism and found that β-HPVs act as co-factors that 
enhance the mutagenic capacity of UV-exposure by disrupting the repair of DSBs.35 In 
addition, genetic polymorphisms in DSB repair genes like XRCC2 and XRCC3 have been 
demonstrated to confer predispositions to UV-induced skin cancer.13 Therefore, it is 
biological plausible that DSBs are involved in the development of UV-induced skin cancer 
and impairment of DSBs repair process could increase risk of skin cancer. SNPs in human 
MUS81 that reduce protein activity have been proposed as breast cancer susceptibility 
factors.36 Moreover, reduced MUS81 expression has been observed in human carcinomas, 
including gastric carcinoma, colon carcinoma, and hepatocellular carcinoma.37–39 Our data 
suggest that common variation in MUS81 plays a role in the development of BCC.
The third index SNP, rs57343616, is located in the 3′ untranslated region (UTR) of the 
NABP2 gene, which has been associated with DNA repair. NABP2, also known as hSSB1, is 
one of the single-stranded DNA (ssDNA)-binding proteins (SSBs), which are ubiquitous and 
essential for a variety of DNA metabolic processes, including replication, recombination, 
damage detection, and repair.40 Previous studies verified the importance of NABP2 in the 
repair of DNA double-strand breaks via homologous recombination and in the maintenance 
and repair of DNA replication forks.41,42 New evidence proved that NABP2 is also 
indispensable following oxidative damage. Cells lacking NABP2 are sensitive to oxidizing 
agents, have deficient ATM and p53 activation, and cannot effectively repair the oxidation of 
DNA by reactive oxygen species (ROS).43 The present study provides the first evidence for 
an association between NABP2 gene variation and skin cancer risk.
Based on a large genome-wide association meta-analysis, we identified three novel BCC 
susceptibility loci with roles in DNA repair. To our knowledge, this is the most 
comprehensive evaluation of common inherited variation in candidate DNA-damage repair 
pathway genes in relation to BCC risk. Some potential limitations of our study also merit 
discussion. First, the present study included only unrelated U.S. Caucasians, which lacked 
racial and geographic diversity. We need future studies in other populations from different 
ethnic backgrounds or geographical areas to confirm our findings and their generalizability. 
Second, age and gender were not perfectly matched between cases and controls in this study. 
However, it is very common for GWAS studies to use controls that are not matched for 
demographic factors.44–47 Notably, age for the most part is not a confounder in SNP 
association tests. In the present study, we included age, gender, and genetic principal 
components in our regressions as covariates. This kind of study design with the participants 
from the Harvard and 23andMe cohorts have been used in many other GWAS studies.
24, 48, 49
 In sum, our findings suggest that the inherited common variation in XPA, MUS81, 
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and NABP2 may be involved in the development of BCC. Further work is warranted on the 
functional characterization of index and linked SNPs in these regions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What’s new?
Genetic variations in DNA repair pathway genes may influence BCC susceptibility. Here, 
single nucleotide polymorphisms (SNPs) across 165 DNA repair pathway genes were 
examined for associations with BCC risk. Three new BCC susceptibility loci were 
identified, and additional BCC risk variants were located within two previously reported 
regions. The findings warrant further study of the relevance to BCC development of three 
DNA repair genes- XPA, MUS81 and NABP2.
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